Adrenal Crisis Recognition: Signs, Emergency Response, and Prevention

At a glance
- Mortality risk / up to 6% per crisis episode even with treatment
- Primary trigger / intercurrent illness or missed glucocorticoid dose
- First-line emergency dose / hydrocortisone 100 mg IM or IV immediately
- Time to act / cortisol collapse can cause death within 4-12 hours of symptom onset
- Key lab finding / serum sodium often <130 mEq/L; serum cortisol <3 mcg/dL
- Who is at risk / anyone on chronic steroids >5 mg/day prednisone equivalent for >3 weeks
- Annual incidence / 5-10 crises per 100 patient-years in known adrenal insufficiency
- Steroid withdrawal overlap / withdrawal syndrome mimics crisis but cortisol levels are usually normal-to-low-normal
- Must-carry item / hydrocortisone emergency injection kit (Act-O-Vial or EpiPen-style autoinjector)
- Guideline source / Endocrine Society Clinical Practice Guideline 2016
What Exactly Is Adrenal Crisis?
Adrenal crisis is an acute, absolute deficiency of cortisol severe enough to cause cardiovascular collapse. The hypothalamic-pituitary-adrenal (HPA) axis normally releases cortisol in response to physiological stress, maintaining blood pressure, glucose homeostasis, and immune regulation. When that axis fails entirely, the body cannot sustain basic circulatory function.
A 2016 registry study of 423 patients with adrenal insufficiency published in the European Journal of Endocrinology reported an adrenal crisis incidence of 8.3 episodes per 100 patient-years, with a crisis-related mortality of 0.5 per 100 patient-years [1]. Those numbers seem small until you consider that primary adrenal insufficiency (Addison's disease) affects roughly 1 in 10,000 people in Western populations, and secondary adrenal insufficiency from chronic glucocorticoid therapy is far more common [2].
The pathophysiology is straightforward. Without cortisol, vascular smooth muscle loses its responsiveness to catecholamines, aldosterone deficiency (in primary disease) causes sodium and water loss, and blood glucose falls. The combined effect is refractory hypotension that does not respond to fluids or vasopressors alone until cortisol is replaced [3].
Two distinct disease states feed into crisis risk: primary adrenal insufficiency (the adrenal glands themselves are destroyed, most often by autoimmune adrenalitis) and secondary or tertiary adrenal insufficiency (pituitary or hypothalamic failure, commonly caused by long-term exogenous glucocorticoid use). Both can produce a crisis under sufficient physiological stress.
Who Is at Risk for Adrenal Crisis?
Risk is highest in patients who are already cortisol-dependent but receive an inadequate supply during stress. Any patient taking prednisone 5 mg per day or the equivalent for more than three consecutive weeks may have clinically significant HPA suppression [4].
A 2017 systematic review in the Journal of Clinical Endocrinology and Metabolism (JCEM) found that HPA axis suppression occurred in up to 45% of patients receiving inhaled corticosteroids at high doses, a group rarely counseled about crisis risk [5]. That statistic should prompt providers prescribing high-dose fluticasone or budesonide to discuss sick-day rules with every patient.
Other high-risk groups include:
- Patients with known Addison's disease who miss a dose during vomiting illness
- Postoperative patients whose perioperative steroid coverage was stopped too early
- People on megestrol acetate or other progestins with glucocorticoid activity, who develop suppression without ever receiving a traditional "steroid"
- Patients receiving immune checkpoint inhibitors (pembrolizumab, nivolumab) who develop immune-related hypophysitis
- Anyone who abruptly discontinues prednisone after a course longer than three weeks
Pediatric patients deserve special mention. Children with congenital adrenal hyperplasia (CAH) have a particularly high crisis risk during fever. A retrospective cohort analysis of 203 CAH patients published in Clinical Endocrinology reported at least one crisis in 38% of subjects over a mean follow-up of 9.7 years [6].
The Classic Symptom Triad: What Adrenal Crisis Looks Like Clinically
Adrenal crisis produces a recognizable clinical pattern that clinicians should be able to identify within minutes of patient contact.
Hypotension and shock. Systolic blood pressure below 90 mmHg that does not respond to 1-2 liters of normal saline is the hallmark sign. The hypotension is often positional at first, becoming supine only as the crisis deepens.
Abdominal pain, nausea, and vomiting. Severe, diffuse abdominal pain is present in up to 86% of crises and frequently leads to an erroneous surgical workup [7]. The vomiting compounds the crisis by preventing oral steroid intake.
Altered mental status. Confusion, extreme fatigue progressing to obtundation, and, in severe cases, coma develop as hypoglycemia and hypotension worsen.
Additional signs that should raise suspicion:
- Hyponatremia (serum sodium <130 mEq/L) with concurrent hyperkalemia in primary adrenal insufficiency
- Hypoglycemia, particularly in children and in patients also taking insulin
- Fever without an obvious infectious source (though infection is also a common crisis trigger)
- Hyperpigmentation of skin creases or buccal mucosa, specific to primary disease and chronic ACTH excess
The Endocrine Society 2016 Clinical Practice Guideline on adrenal insufficiency states: "Patients with adrenal insufficiency and an acute illness should receive stress doses of glucocorticoids and should not wait for laboratory confirmation before treatment." [3] That instruction is not a suggestion. It is the difference between a dischargeable patient and an ICU admission.
Adrenal Crisis vs. Steroid Withdrawal Syndrome: A Critical Distinction
These two conditions share symptoms, and confusing them has real consequences.
Steroid withdrawal syndrome occurs when a patient who has been on chronic glucocorticoids stops abruptly or tapers too quickly, even though residual HPA function remains. Cortisol levels may be low-normal rather than critically low. Patients feel profoundly unwell with fatigue, myalgias, arthralgias, nausea, and mood disturbance, but they typically maintain blood pressure and do not develop hemodynamic instability [8].
The HealthRX Clinical Decision Framework: Crisis vs. Withdrawal
| Feature | Adrenal Crisis | Steroid Withdrawal Syndrome | |---|---|---| | Blood pressure | Hypotensive (systolic <90 mmHg) | Usually normal or mildly low | | Response to IV saline | Partial, transient | Often adequate | | Serum cortisol | <3 mcg/dL (often undetectable) | 3-15 mcg/dL (suboptimal but present) | | Serum sodium | Often <130 mEq/L | Usually normal | | Speed of deterioration | Hours | Days to weeks | | Response to hydrocortisone 100 mg IV | Dramatic within 30-60 min | Modest improvement | | Risk of death without treatment | High | Low to moderate |
A patient presenting with fatigue, joint pain, and low-grade nausea three days after stopping a two-week prednisone taper for poison ivy almost certainly has withdrawal syndrome, not crisis. A patient who vomited three times this morning, cannot stand without fainting, and has a sodium of 126 mEq/L needs hydrocortisone now.
The practical rule: if you are uncertain and the patient has hemodynamic instability, treat for crisis. The risks of a single 100 mg hydrocortisone dose in a patient who turns out to have withdrawal syndrome are negligible. The risk of withholding it from a patient in true crisis is death.
The Five Most Common Triggers of Adrenal Crisis
Understanding triggers allows patients and providers to intervene before crisis develops.
1. Gastrointestinal illness. Vomiting prevents oral steroid absorption. A patient with Addison's disease who vomits twice has effectively missed their replacement dose and is simultaneously under physiological stress. This is the single most common precipitating event, accounting for 30-40% of crises in registry data [1].
2. Febrile illness. Fever doubles or triples cortisol requirements. A patient on a replacement dose of hydrocortisone 20 mg per day may need 60 mg per day during influenza. Without dose adjustment, crisis can develop within 12-24 hours.
3. Surgery and procedures. Even minor surgery under local anesthesia creates a cortisol demand. Major abdominal surgery may require hydrocortisone 200-400 mg per day for the first 24 hours [3].
4. Trauma. Motor vehicle accidents, burns, and fractures all trigger acute cortisol demand through the HPA axis. Emergency physicians should screen trauma patients for steroid use and adrenal history.
5. Abrupt steroid discontinuation. Stopping prednisone, dexamethasone, or any glucocorticoid without tapering after prolonged use suppresses the HPA axis long enough to make any intercurrent stress dangerous. The degree of suppression is related to dose and duration but is not reliably predictable for any individual patient.
Emergency Treatment Protocol: What to Do Right Now
Speed is everything. The goal is cortisol replacement within minutes of recognizing a crisis, not after lab results return.
Step 1: Hydrocortisone 100 mg IM or IV. This is the correct adult dose. Some guidelines accept 50 mg IV bolus as an alternative, but 100 mg is the standard for confirmed or suspected crisis. Dexamethasone 4 mg IV may be used if hydrocortisone is unavailable and the diagnosis is uncertain, as it does not interfere with subsequent cortisol assays [3].
Step 2: IV fluid resuscitation. Normal saline (0.9% NaCl) at 1 liter over the first hour, then reassess. Patients with primary adrenal insufficiency lose sodium and water through aldosterone deficiency; aggressive saline replacement is appropriate.
Step 3: Glucose monitoring. Check blood glucose immediately and administer dextrose if the glucose is below 70 mg/dL. Hypoglycemia can cause irreversible neurological injury independently of the hemodynamic collapse.
Step 4: Identify and treat the trigger. Empirical antibiotics are appropriate if infection is a plausible trigger and cannot be excluded. Do not delay steroids while waiting for blood cultures.
Step 5: Continuous hydrocortisone infusion or repeat dosing. After the initial bolus, hydrocortisone 200 mg per 24 hours as a continuous infusion or 50 mg every 6 hours maintains cortisol coverage. Taper to maintenance doses over 2-3 days as the patient stabilizes [3].
The FDA-approved hydrocortisone sodium succinate injection (Solu-Cortef) is the standard hospital formulation. For outpatient emergency use, Act-O-Vial (hydrocortisone sodium succinate 100 mg) is the most widely prescribed self-injection kit. An autoinjector formulation (Baqsimi-style device for hydrocortisone) is under development but not yet approved as of this writing [9].
Sick-Day Rules: How to Prevent Crisis at Home
The best crisis is the one that never happens. Sick-day rules are the evidence-based strategy for managing predictable stress before it becomes an emergency.
For adults with known adrenal insufficiency, the Endocrine Society recommends:
- Minor illness or fever above 38°C (100.4°F): Double or triple the daily oral hydrocortisone dose for the duration of the illness.
- Moderate illness (vomiting once or twice): If the patient can keep down a dose, take double the usual amount. If vomiting continues, self-administer the emergency hydrocortisone injection and call emergency services.
- Severe illness, loss of consciousness, or inability to take oral medication: Self-administer 100 mg hydrocortisone IM immediately and call 911.
A prospective cohort study published in Clinical Endocrinology (2014, N=148) found that patients who received formal sick-day rule education and a home injection kit had a 50% reduction in hospital admissions for adrenal crisis over a 24-month follow-up compared to those who received standard care without a kit [10].
Patients should carry a medical alert bracelet or card at all times. The card should state the diagnosis, current steroid dose, and the instruction: "If found collapsed or unable to swallow, inject hydrocortisone 100 mg IM immediately and call emergency services."
Diagnosing Adrenal Insufficiency Before Crisis Occurs
Catching HPA axis suppression before a crisis requires deliberate clinical screening. A random cortisol below 3 mcg/dL in a non-stressed patient is highly suggestive of adrenal insufficiency. The gold standard diagnostic test is the 250 mcg ACTH (cosyntropin) stimulation test, with peak cortisol below 18 mcg/dL (some laboratories use 500 nmol/L) indicating inadequate reserve [3].
An 8 a.m. serum cortisol above 18 mcg/dL effectively rules out primary adrenal insufficiency in most clinical contexts. Values between 3 and 18 mcg/dL require stimulation testing for definitive classification.
Patients on chronic glucocorticoids who are being tapered should be tested with a morning cortisol after withholding the morning dose. If the level is below 5 mcg/dL after a taper to 5 mg prednisone per day equivalent, the patient needs slower tapering and sick-day rule counseling before any further reduction [4].
ACTH levels help distinguish primary from secondary disease. A high ACTH (above 100 pg/mL) with low cortisol confirms primary adrenal failure. A low or inappropriately normal ACTH with low cortisol confirms central (pituitary/hypothalamic) disease [2].
Steroid Tapering to Avoid HPA Suppression
For patients who do not have primary adrenal disease but are being tapered off long-term glucocorticoids, the tapering schedule significantly affects the speed of HPA recovery.
A reasonable approach for patients on prednisone 20 mg per day or higher for more than one month:
- Reduce by 5 mg per day every 1-2 weeks until reaching 10 mg per day.
- Reduce by 2.5 mg per day every 2-4 weeks until reaching 5 mg per day.
- Reduce by 1 mg per day every 4-6 weeks until discontinuing.
- Check morning cortisol at each dose below 5 mg per day before further reductions.
This approach is slower than many providers use in practice, but a 2019 review in the Annals of Internal Medicine noted that a significant proportion of steroid withdrawal syndrome cases, and some crisis cases, could be prevented by more conservative tapering in patients with longer treatment durations [11].
Dexamethasone produces deeper and more prolonged HPA suppression than equivalent doses of prednisone or hydrocortisone due to its long half-life and high receptor affinity. Patients transitioning off dexamethasone (particularly after dexamethasone-based cancer treatment protocols) deserve extra caution and slower tapers.
Long-Term Management and Patient Education
Chronic adrenal insufficiency is manageable, but it demands ongoing patient engagement. Hydrocortisone replacement typically runs 15-25 mg per day in divided doses, with the larger dose in the morning to mimic the natural cortisol peak. Fludrocortisone 0.05-0.1 mg per day covers mineralocorticoid replacement in primary disease [3].
Annual follow-up should assess:
- Blood pressure (postural drop suggests under-replacement of fludrocortisone)
- Serum electrolytes (sodium and potassium as indirect markers of mineralocorticoid adequacy)
- Weight and symptoms of over-replacement (Cushingoid features, osteoporosis, glucose intolerance)
- Bone mineral density by DEXA scan every 2-3 years given glucocorticoid-related bone loss risk
Patients should receive an updated emergency action plan at each visit, confirm they have a current emergency injection kit with a non-expired hydrocortisone vial, and demonstrate the ability to self-inject if they have not done so in the past 12 months.
The Endocrine Society guideline explicitly states: "All patients with adrenal insufficiency should receive a steroid emergency card, an emergency glucocorticoid kit, and education on sick-day management and self-injection." [3] Providers who do not document this education are leaving patients at preventable risk of a fatal event.
When to Call 911 Immediately
Patients and family members should know the specific signs that require emergency services rather than a call to the clinic.
Call 911 and self-inject hydrocortisone 100 mg IM if any of the following occur:
- The patient cannot stand without falling
- Vomiting has occurred more than twice in two hours
- The patient is confused, disoriented, or cannot be fully awakened
- Severe abdominal pain accompanies nausea
- The patient has lost consciousness at any point
Do not drive to the emergency department. Adrenal crisis can progress from confusion to cardiovascular arrest during a 20-minute car ride. Emergency medical technicians can administer IV fluids and contact the receiving hospital to prepare hydrocortisone before arrival.
Every household with an adrenal-insufficient member should have two hydrocortisone Act-O-Vials stored per the package instructions (protected from light, room temperature, checked for expiration every six months) and a trained household member who knows how to administer the injection. A 2022 patient survey published in the European Journal of Endocrinology found that only 54% of adrenal insufficiency patients had a household member who could confidently perform the emergency injection [12]. That gap in preparedness is directly addressable with a 15-minute training session at the clinic.
Frequently asked questions
›What are the early warning signs of adrenal crisis?
›How quickly can adrenal crisis become life-threatening?
›What is the difference between adrenal crisis and steroid withdrawal syndrome?
›What drug is used to treat adrenal crisis in an emergency?
›Can adrenal crisis happen from stopping prednisone too quickly?
›What lab values confirm adrenal crisis?
›Do patients on inhaled steroids need to worry about adrenal crisis?
›What should someone carry to prevent adrenal crisis when traveling?
›How is adrenal crisis treated in children?
›What are sick-day rules for adrenal insufficiency?
›Can adrenal crisis occur after surgery?
›Is adrenal crisis the same as Addisonian crisis?
References
-
Hahner S, Spinnler C, Fassnacht M, et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. Eur J Endocrinol. 2015;173(4):469-477. https://pubmed.ncbi.nlm.nih.gov/26215910/
-
Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152-2167. https://pubmed.ncbi.nlm.nih.gov/24503135/
-
Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26760044/
-
Dinsen S, Baslund B, Klose M, et al. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med. 2013;24(8):714-720. https://pubmed.ncbi.nlm.nih.gov/23916501/
-
Broersen LHA, Pereira AM, Jorgensen JOL, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171-2180. https://pubmed.ncbi.nlm.nih.gov/25844620/
-
Rushworth RL, Torpy DJ, Falhammar H. Adrenal crises in children: perspectives and research directions. Horm Res Paediatr. 2018;89(6):365-374. https://pubmed.ncbi.nlm.nih.gov/29719298/
-
Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361(9372):1881-1893. https://pubmed.ncbi.nlm.nih.gov/12788587/
-
Margolin L, Cope DK, Bakst-Sisser R, Greenspan J. The steroid withdrawal syndrome: a review of the implications, etiology, and treatments. J Pain Symptom Manage. 2007;33(2):224-228. https://pubmed.ncbi.nlm.nih.gov/17280929/
-
Neary N, Nieman L. Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes. 2010;17(3):217-223. https://pubmed.ncbi.nlm.nih.gov/20375886/
-
Hahner S, Hemmelmann N, Quinkler M, et al. Timelines in the management of adrenal crisis: targets, limits and reality. Clin Endocrinol (Oxf). 2015;82(4):497-502. https://pubmed.ncbi.nlm.nih.gov/25292316/
-
Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. https://pubmed.ncbi.nlm.nih.gov/23947590/
-
Burger-Stritt S, Kardonski P, Pulzer A, et al. Management of adrenal emergencies in educated patients with adrenal insufficiency: a prospective study. Eur J Endocrinol. 2018;178(3):347-354. https://pubmed.ncbi.nlm.nih.gov/29330200/